Eva Rivero‐Buceta

595 total citations
20 papers, 473 citations indexed

About

Eva Rivero‐Buceta is a scholar working on Molecular Biology, Materials Chemistry and Biomaterials. According to data from OpenAlex, Eva Rivero‐Buceta has authored 20 papers receiving a total of 473 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Materials Chemistry and 5 papers in Biomaterials. Recurrent topics in Eva Rivero‐Buceta's work include Nanoparticle-Based Drug Delivery (5 papers), Nanoplatforms for cancer theranostics (5 papers) and HIV Research and Treatment (4 papers). Eva Rivero‐Buceta is often cited by papers focused on Nanoparticle-Based Drug Delivery (5 papers), Nanoplatforms for cancer theranostics (5 papers) and HIV Research and Treatment (4 papers). Eva Rivero‐Buceta collaborates with scholars based in Spain, Belgium and United States. Eva Rivero‐Buceta's co-authors include Pablo Botella, Victoria Moreno‐Manzano, Eduardo Fernández, C.D. Vera Donoso, Avelino Corma, Ana San‐Félix, Christopher C. Landry, Ernesto Quesada, Marı́a-José Camarasa and Elisa G. Doyagüez and has published in prestigious journals such as Journal of Colloid and Interface Science, Journal of Controlled Release and Nanoscale.

In The Last Decade

Eva Rivero‐Buceta

19 papers receiving 470 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Rivero‐Buceta Spain 13 171 170 155 114 70 20 473
Bowen Jiang China 13 92 0.5× 179 1.1× 223 1.4× 90 0.8× 17 0.2× 42 597
Ping Gao China 11 94 0.5× 141 0.8× 168 1.1× 97 0.9× 30 0.4× 14 632
Qizhen Zheng China 12 65 0.4× 101 0.6× 230 1.5× 128 1.1× 123 1.8× 21 485
Yonghuang Luo China 10 109 0.6× 170 1.0× 127 0.8× 60 0.5× 6 0.1× 14 457
Martine Appel France 14 303 1.8× 118 0.7× 241 1.6× 61 0.5× 10 0.1× 17 633
Jinghua Duan United States 14 270 1.6× 146 0.9× 252 1.6× 82 0.7× 4 0.1× 19 702
Estefanía Grotz Argentina 5 199 1.2× 146 0.9× 129 0.8× 66 0.6× 7 0.1× 5 433
Badri Parshad Germany 16 180 1.1× 210 1.2× 238 1.5× 102 0.9× 29 0.4× 34 661
Mrunal Jadhav India 6 200 1.2× 132 0.8× 196 1.3× 65 0.6× 12 0.2× 8 584

Countries citing papers authored by Eva Rivero‐Buceta

Since Specialization
Citations

This map shows the geographic impact of Eva Rivero‐Buceta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Rivero‐Buceta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Rivero‐Buceta more than expected).

Fields of papers citing papers by Eva Rivero‐Buceta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Rivero‐Buceta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Rivero‐Buceta. The network helps show where Eva Rivero‐Buceta may publish in the future.

Co-authorship network of co-authors of Eva Rivero‐Buceta

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Rivero‐Buceta. A scholar is included among the top collaborators of Eva Rivero‐Buceta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Rivero‐Buceta. Eva Rivero‐Buceta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gómez, Leyre, et al.. (2025). Preparation of mesoporous silica nanoparticles by spray drying. Microporous and Mesoporous Materials. 393. 113646–113646.
2.
Rivero‐Buceta, Eva, et al.. (2024). Prostate cancer chemotherapy by intratumoral administration of Docetaxel-Mesoporous silica nanomedicines. International Journal of Pharmaceutics. 664. 124623–124623. 8 indexed citations
3.
Rivero‐Buceta, Eva, et al.. (2023). Light-activated controlled release of camptothecin by engineering porous materials: the ship in a bottle concept in drug delivery. Nanoscale. 15(30). 12506–12517. 8 indexed citations
4.
Macchione, Micaela A., et al.. (2022). Mesoporous Silica and Oligo (Ethylene Glycol) Methacrylates-Based Dual-Responsive Hybrid Nanogels. Nanomaterials. 12(21). 3835–3835. 6 indexed citations
5.
Corma, Avelino, Pablo Botella, & Eva Rivero‐Buceta. (2022). Silica-Based Stimuli-Responsive Systems for Antitumor Drug Delivery and Controlled Release. Pharmaceutics. 14(1). 110–110. 34 indexed citations
6.
Rivero‐Buceta, Eva, et al.. (2021). Isolation and Quantification of miRNA from the Biomolecular Corona on Mesoporous Silica Nanoparticles. Nanomaterials. 11(5). 1196–1196. 3 indexed citations
7.
Rivero‐Buceta, Eva, et al.. (2021). Development of a Prodrug of Camptothecin for Enhanced Treatment of Glioblastoma Multiforme. Molecular Pharmaceutics. 18(4). 1558–1572. 12 indexed citations
8.
Rivero‐Buceta, Eva, Victoria Moreno‐Manzano, J.L. Jordá, et al.. (2020). Sequential pore wall functionalization in covalent organic frameworks and application to stable camptothecin delivery systems. Materials Science and Engineering C. 117. 111263–111263. 19 indexed citations
9.
Sun, Liang, Hyunwook Lee, Hendrik Jan Thibaut, et al.. (2019). Viral engagement with host receptors blocked by a novel class of tryptophan dendrimers that targets the 5-fold-axis of the enterovirus-A71 capsid. PLoS Pathogens. 15(5). e1007760–e1007760. 25 indexed citations
10.
Rivero‐Buceta, Eva, et al.. (2019). Amino modified metal-organic frameworks as pH-responsive nanoplatforms for safe delivery of camptothecin. Journal of Colloid and Interface Science. 541. 163–174. 54 indexed citations
11.
12.
Rivero‐Buceta, Eva, et al.. (2019). PSMA-Targeted Mesoporous Silica Nanoparticles for Selective Intracellular Delivery of Docetaxel in Prostate Cancer Cells. ACS Omega. 4(1). 1281–1291. 39 indexed citations
13.
Pacheco‐Torres, Jesús, Ángela Bernabéu, Alejandro Vidal‐Moya, et al.. (2018). Engineered contrast agents in a single structure forT1–T2dual magnetic resonance imaging. Nanoscale. 10(14). 6349–6360. 16 indexed citations
14.
Botella, Pablo & Eva Rivero‐Buceta. (2016). Safe approaches for camptothecin delivery: Structural analogues and nanomedicines. Journal of Controlled Release. 247. 28–54. 90 indexed citations
15.
Sun, Liang, Eva Rivero‐Buceta, Aída Flores, et al.. (2016). Structure-activity relationship studies on a Trp dendrimer with dual activities against HIV and enterovirus A71. Modifications on the amino acid. Antiviral Research. 139. 32–40. 18 indexed citations
16.
Rivero‐Buceta, Eva, Liang Sun, Elisa G. Doyagüez, et al.. (2016). Optimization of a Class of Tryptophan Dendrimers That Inhibit HIV Replication Leads to a Selective, Specific, and Low-Nanomolar Inhibitor of Clinical Isolates of Enterovirus A71. Antimicrobial Agents and Chemotherapy. 60(8). 5064–5067. 16 indexed citations
17.
Rivero‐Buceta, Eva, Elisa G. Doyagüez, Andrés Madrona, et al.. (2015). Linear and branched alkyl-esters and amides of gallic acid and other (mono-, di- and tri-) hydroxy benzoyl derivatives as promising anti-HCV inhibitors. European Journal of Medicinal Chemistry. 92. 656–671. 33 indexed citations
18.
Rivero‐Buceta, Eva, Elena Casanova, Elisa G. Doyagüez, et al.. (2015). Anti-HIV-1 activity of a tripodal receptor that recognizes mannose oligomers. European Journal of Medicinal Chemistry. 106. 132–143. 10 indexed citations
19.
Rivero‐Buceta, Eva, Elisa G. Doyagüez, Ignacio Colomer, et al.. (2015). Tryptophan dendrimers that inhibit HIV replication, prevent virus entry and bind to the HIV envelope glycoproteins gp120 and gp41. European Journal of Medicinal Chemistry. 106. 34–43. 24 indexed citations
20.
Ardá, Ana, M. Álvarez, Elisa G. Doyagüez, et al.. (2012). Differential Recognition of Mannose‐Based Polysaccharides by Tripodal Receptors Based on a Triethylbenzene Scaffold Substituted with Trihydroxybenzoyl Moieties. European Journal of Organic Chemistry. 2013(1). 65–76. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bowen Jiang Breakdown of academic impact, for papers by Ping Gao Breakdown of academic impact, for papers by Qizhen Zheng Breakdown of academic impact, for papers by Yonghuang Luo Breakdown of academic impact, for papers by Martine Appel Breakdown of academic impact, for papers by Jinghua Duan Breakdown of academic impact, for papers by Estefanía Grotz Breakdown of academic impact, for papers by Badri Parshad Breakdown of academic impact, for papers by Mrunal Jadhav
Rankless by CCL
2026